Fatima Rizvi

712 total citations · 1 hit paper
21 papers, 482 citations indexed

About

Fatima Rizvi is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Fatima Rizvi has authored 21 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Surgery and 3 papers in Oncology. Recurrent topics in Fatima Rizvi's work include Genomics, phytochemicals, and oxidative stress (4 papers), Liver physiology and pathology (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Fatima Rizvi is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (4 papers), Liver physiology and pathology (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Fatima Rizvi collaborates with scholars based in United States, India and Pakistan. Fatima Rizvi's co-authors include Poonam Kakkar, Shatrunajay Shukla, Alpana Mathur, Sheikh Raisuddin, Radhika Kapoor, Anna R. Smith, Drew Weissman, Ying K. Tam, Valerie Gouon–Evans and Norbert Pardi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Fatima Rizvi

17 papers receiving 481 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA

2021 103 citations Fatima Rizvi, Anna R. Smith et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fatima Rizvi United States	9	290	62	61	55	50	21	482
Bong‐Jo Kim South Korea	11	398 1.4×	96 1.5×	37 0.6×	41 0.7×	63 1.3×	19	607
Hao Feng China	14	296 1.0×	51 0.8×	56 0.9×	37 0.7×	21 0.4×	49	524
Noha A. Amin Egypt	12	267 0.9×	82 1.3×	30 0.5×	27 0.5×	23 0.5×	13	472
Jesper J. Hedberg Sweden	14	229 0.8×	62 1.0×	67 1.1×	24 0.4×	71 1.4×	22	506
Weiwei Rong China	14	312 1.1×	38 0.6×	38 0.6×	35 0.6×	30 0.6×	36	534
Shuling Zhang China	10	180 0.6×	93 1.5×	76 1.2×	35 0.6×	23 0.5×	18	385
Zixin Zhu China	13	306 1.1×	96 1.5×	43 0.7×	95 1.7×	112 2.2×	22	668
Linan Zhao China	11	201 0.7×	44 0.7×	49 0.8×	21 0.4×	23 0.5×	25	495
Jinque Luo China	14	233 0.8×	63 1.0×	27 0.4×	41 0.7×	33 0.7×	28	541
Ahmed Lawan United States	12	365 1.3×	127 2.0×	22 0.4×	33 0.6×	79 1.6×	24	563

Countries citing papers authored by Fatima Rizvi

Since Specialization

Citations

This map shows the geographic impact of Fatima Rizvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatima Rizvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatima Rizvi more than expected).

Fields of papers citing papers by Fatima Rizvi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatima Rizvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatima Rizvi. The network helps show where Fatima Rizvi may publish in the future.

Co-authorship network of co-authors of Fatima Rizvi

This figure shows the co-authorship network connecting the top 25 collaborators of Fatima Rizvi. A scholar is included among the top collaborators of Fatima Rizvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatima Rizvi. Fatima Rizvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Srivastava, Geetika, Rupert W. Leong, Abhilasha Nair, et al.. (2024). U.S. FDA analysis of enrollment of Asian patients from India in cancer clinical trials leading to approval from 2010 to 2022.. Journal of Clinical Oncology. 42(16_suppl). e13779–e13779. 1 indexed citations

Swain, Raghunandan, Andrew J. Klink, Bindu Kalesan, et al.. (2024). MSR101 A Novel Methodology for Assessing Response to Lymphoma Treatment in Real-World Studies – the Real-World Lugano (RWLUGANO) Study. Value in Health. 27(6). S279–S279.

Smith, Anna R., Fatima Rizvi, Ying K. Tam, et al.. (2024). Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy in mice. Nature Communications. 15(1). 5010–5010. 6 indexed citations

Kim, Minwook, Fatima Rizvi, Donghun Shin, & Valerie Gouon–Evans. (2023). Update on Hepatobiliary Plasticity. Seminars in Liver Disease. 43(1). 13–23. 2 indexed citations

Rizvi, Fatima, et al.. (2023). Anti-cancer activity of Mebendazole, Metformin and Apricoxib in HT-29, MDA-MB-231 HelaandMCF-7cell lines: Preclinical trial. 17(1). 47–51.

Akinboro, Oladimeji, Fatima Rizvi, Pallavi S. Mishra‐Kalyani, et al.. (2023). Abstract A025: Enrollment of older adults in small cell lung cancer (SCLC) clinical trials compared with population-based U.S. incidence estimates. Cancer Research. 83(2_Supplement_1). A025–A025.

Rizvi, Fatima, Anna R. Smith, Hua Liu, et al.. (2021). Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA. Nature Communications. 12(1). 613–613. 103 indexed citations breakdown →

Rizvi, Fatima, et al.. (2021). Preclinical meritorious anticancer effects of Metformin against breast cancer: An In vivo trial. Journal of Taibah University Medical Sciences. 16(4). 504–512. 2 indexed citations

Rizvi, Fatima, Anna R. Smith, Mitchell Beattie, et al.. (2021). Transient yet Robust Expression of Proteins in the Mouse Liver via Intravenous Injection of Lipid Nanoparticle-encapsulated Nucleoside-modified mRNA. BIO-PROTOCOL. 11(19). e4184–e4184. 8 indexed citations

10.

Akella, Jyothi S., Ken C. Q. Nguyen, Sofia Tsiropoulou, et al.. (2020). Ciliary Rab28 and the BBSome negatively regulate extracellular vesicle shedding. eLife. 9. 38 indexed citations

11.

Rizvi, Fatima, et al.. (2020). Miracle medicine for prevention of migraine attack: Metformin.. The Professional Medical Journal. 27(4). 812–819. 2 indexed citations

12.

Rizvi, Fatima, et al.. (2020). Promising role of Metformin in reducing the viability of breast cancerous cells.. PubMed. 33(2). 543–549. 2 indexed citations

13.

Rizvi, Fatima, et al.. (2018). Mebendazole Inexplicably Reducing the Breast Cancer Cells Viability Preclinically by Incitement Effects with Methotrexate. 6(2). 101–106. 1 indexed citations

14.

Imran, Muhammad, et al.. (2018). Role of bladder washing cytology with fresh voided urine cytology in the diagnosis of urothelial malignancy. 12(4).

15.

Mathur, Alpana, Fatima Rizvi, & Poonam Kakkar. (2016). PHLPP2 down regulation influences nuclear Nrf2 stability via Akt-1/Gsk3β/Fyn kinase axis in acetaminophen induced oxidative renal toxicity: Protection accorded by morin. Food and Chemical Toxicology. 89. 19–31. 42 indexed citations

16.

Rizvi, Fatima, Alpana Mathur, Shagun Krishna, Mohammad Imran Siddiqi, & Poonam Kakkar. (2015). Suppression in PHLPP2 induction by morin promotes Nrf2-regulated cellular defenses against oxidative injury to primary rat hepatocytes. Redox Biology. 6. 587–598. 36 indexed citations

17.

Rizvi, Fatima, Alpana Mathur, & Poonam Kakkar. (2015). Morin mitigates acetaminophen-induced liver injury by potentiating Nrf2 regulated survival mechanism through molecular intervention in PHLPP2-Akt-Gsk3β axis. APOPTOSIS. 20(10). 1296–1306. 49 indexed citations

18.

Shukla, Shatrunajay, Fatima Rizvi, Sheikh Raisuddin, & Poonam Kakkar. (2014). FoxO proteins’ nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells. Free Radical Biology and Medicine. 76. 185–199. 72 indexed citations

19.

Rizvi, Fatima, Shatrunajay Shukla, & Poonam Kakkar. (2014). Essential role of PH domain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt/GSK3β/Fyn kinase axis during oxidative hepatocellular toxicity. Cell Death and Disease. 5(3). e1153–e1153. 62 indexed citations

20.

Kapoor, Radhika, Fatima Rizvi, & Poonam Kakkar. (2012). Naringenin prevents high glucose-induced mitochondria-mediated apoptosis involving AIF, Endo-G and caspases. APOPTOSIS. 18(1). 9–27. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact